Education
About Us
Working with TipRanks
Follow Us
Biolidics Ltd. (SG:8YY)
SGX:8YY
Total Valuation
Biolidics Ltd. has a market cap or net worth of S$88.41M. The enterprise value is S$90.26M.
Market CapS$88.41M
Enterprise ValueS$90.26M
Share Statistics
Biolidics Ltd. has 1,733,441,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,733,441,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biolidics Ltd.’s return on equity (ROE) is -2.59 and return on invested capital (ROIC) is -75.44%.
Return on Equity (ROE)-2.59
Return on Assets (ROA)-0.78
Return on Invested Capital (ROIC)-75.44%
Return on Capital Employed (ROCE)-0.81
Revenue Per Employee751.29K
Profits Per Employee-570.57K
Employee Count7
Asset Turnover1.04
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biolidics Ltd. is ―. Biolidics Ltd.’s PEG ratio is 0.66.
PE Ratio―
PS Ratio16.93
PB Ratio58.30
Price to Fair Value58.30
Price to FCF-247.30
Price to Operating Cash Flow-33.44
PEG Ratio0.66
Income Statement
In the last 12 months, Biolidics Ltd. had revenue of 5.26M and earned -3.96M in profits. Earnings per share was >-0.01.
Revenue5.26M
Gross Profit1.94M
Operating Income-3.22M
Pretax Income-3.99M
Net Income-3.96M
EBITDA-3.65M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.68M and capital expenditures -6.00K, giving a free cash flow of -2.69M billion.
Operating Cash Flow-2.68M
Free Cash Flow-2.69M
Free Cash Flow per Share>-0.01
Dividends & Yields
Biolidics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change112.50%
50-Day Moving Average0.07
200-Day Moving Average0.03
Relative Strength Index (RSI)40.46
Average Volume (3m)412.95K
Important Dates
Biolidics Ltd. upcoming earnings date is Apr 24, 2026, TBA (Confirmed).
Last Earnings DateFeb 27, 2026
Next Earnings DateApr 24, 2026
Ex-Dividend Date―
Financial Position
Biolidics Ltd. as a current ratio of 1.17, with Debt / Equity ratio of 158.02%
Current Ratio1.17
Quick Ratio1.17
Debt to Market Cap0.03
Net Debt to EBITDA-0.51
Interest Coverage Ratio-40.27
Taxes
In the past 12 months, Biolidics Ltd. has paid -29.00K in taxes.
Income Tax-29.00K
Effective Tax Rate<0.01
Enterprise Valuation
Biolidics Ltd. EV to EBITDA ratio is -24.89, with an EV/FCF ratio of -252.46.
EV to Sales17.28
EV to EBITDA-24.89
EV to Free Cash Flow-252.46
EV to Operating Cash Flow-252.46
Balance Sheet
Biolidics Ltd. has S$300.00K in cash and marketable securities with S$2.52M in debt, giving a net cash position of -S$2.21M billion.
Cash & Marketable SecuritiesS$300.00K
Total DebtS$2.52M
Net Cash-S$2.21M
Net Cash Per Share>-S$0.01
Tangible Book Value Per Share>-S$0.01
Margins
Gross margin is 36.89%, with operating margin of -61.27%, and net profit margin of -75.34%.
Gross Margin36.89%
Operating Margin-61.27%
Pretax Margin-75.95%
Net Profit Margin-75.34%
EBITDA Margin-69.42%
EBIT Margin-74.42%
Analyst Forecast
The average price target for Biolidics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―